Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its supplemental New Drug Application (sNDA) for NUPLAZID® (pimavan
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from its 298 patient Phase 3 CLARITY study which combined two identical, double-blind, placebo-controlled studies evaluating
ACADIA Pharmaceuticals (ACAD) Receives a Buy from Needham - Markets
11:23am, Thursday, 16'th Jul 2020
In a report released today, Alan Carr from Needham assigned a Buy rating to ACADIA Pharmaceuticals (ACAD – Research Report),
Charting a bull-trend whipsaw, S&P 500 nails next resistance
04:35pm, Tuesday, 14'th Jul 2020
Technically speaking, the U.S. benchmarks have registered a mid-July market whipsaw, writes Michael Ashbaugh, pressured at least briefly amid the month’s...
Did Hedge Funds Make The Right Call On ACADIA Pharmaceuticals Inc. (ACAD) ?
12:54am, Monday, 13'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Exane Derivatives Sells 727 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
06:40am, Sunday, 12'th Jul 2020
Exane Derivatives lowered its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) by 15.4% during the second quarter, according to the company in its most recent disclosure with the Securi
Shareholders Are Thrilled That The ACADIA Pharmaceuticals (NASDAQ:ACAD) Share Price Increased 113%
10:51am, Wednesday, 08'th Jul 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
12:00am, Wednesday, 08'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
AbbVie Inc (NYSE: ABBV)...
Why Acadia Pharmaceuticals (ACAD) Stock is a Compelling Investment Case
02:42pm, Tuesday, 07'th Jul 2020
If you are looking for the best ideas for your portfolio you may want to consider some of Mott Capital's top stock picks. Mott Capital, an investment management firm, is bullish on Acadia Pharmaceutic
Acadia Pharmaceuticals: Evaluating The Upcoming Opportunities (NASDAQ:ACAD)
03:07am, Tuesday, 07'th Jul 2020
With the three sNDA approvals in the next three years, the share price is set to soar. Long-term investors could be generously rewarded with returns.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)
ACADIA Pharmaceuticals Inc...
89bio (ETNB) Receives a Buy from Oppenheimer - Markets
10:56am, Thursday, 02'nd Jul 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Bought by Royal Bank of Canada
11:07am, Wednesday, 01'st Jul 2020
Royal Bank of Canada increased its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) by 40.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Co
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Catasys (CATS
